The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...
A Massachusetts-based biotechnology company formerly known as Vaxess Technologies, Terrestrial Bio is developing a proprietary microarray patch platform that enables the temperature-stable, ...
This article and associated images are based on a poster originally authored by Adam Buckle, Julia Unsicker and Iain McWilliam and presented at ELRIG Drug Discovery 2025 in affiliation with Arrayjet ...
cDNA microarray is an innovative technology that facilitates the analysis of the expression of thousands of genes simultaneously. The utilization of this methodology, which is rapidly evolving, ...
Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
[Image from Micron Biomedical website] Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 million. J2 Ventures and the Global ...
According to Precedence Research, the global microarray market size was estimated at USD 5.46 billion in 2023 and is projected to reach USD 13.81 billion by 2034, registering a CAGR of 8.8% from 2024 ...
The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results